Q-Med obtains approval for MACROLANETM VRF in Europe

Report this content

MACROLANE VRF is a natural gel that is injected into the skin. The product is based on Q-Med’s patented technology, NASHA, for the production of stabilized,
non-animal hyaluronic acid. MACROLANE VRF can be used in body contouring both to give volume and to smooth out irregularities all over the body.

“Now there is a product that in a naturally way may recreate the body shapes that have been lost as a consequence of aging. MACROLANE VRF may refine and shape breast, decolletage, buttocks and other parts of the body according to the individual consumer’s needs. Q-Med has conducted research and development for quite some time in this area and we feel very proud today” says Bengt Ågerup, CEO, Q-Med AB.

The first of Q-Med’s products based on NASHA, RESTYLANE, was approved in Europe in 1996 and since then seven million treatments have been performed. MACROLANE VRF will be launched for plastic surgeons during 2007 and 2008.

Documents & Links